Compare HCA Health Inc (HCA) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Royal Caribbean Cruises Ltd — how do they compare? HCA Health Inc trades at $371.96 (market cap $82.17B), while Royal Caribbean Cruises Ltd trades at $288.49 (market cap $76.75B). The key difference: HCA Health Inc and Royal Caribbean Cruises Ltd are close in size by market cap, and Royal Caribbean Cruises Ltd pays the higher dividend (1.75%). Which is the better fit depends on your goals.
| HCA | RCL | |
|---|---|---|
Market Cap | $82.17B | $76.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $365.84 |
52-Week Low | $334.32 | $246.71 |
Enterprise Value | $131.08B | $98.03B |
Dividend Yield | 0.84% | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
Royal Caribbean (RCL) trades at $285.59, down 0.48% on the day, with technical indicators showing a neutral to bullish bias as the stock tests support near $285. Fundamentally, the company demonstrates strong profitability with 24.36% net margins and 50.41% ROE, supported by robust revenue growth from $8.8B in 2022 to $17.93B in 2025. Recent earnings have mostly beaten expectations, with Q1 2026 EPS of $3.60 surpassing estimates of $3.24.
The investment outlook remains positive given analyst consensus price target of $328 (15% upside), strong cash flow generation, and continued recovery in cruise demand. Key risks include high debt levels ($18.47B long-term debt), sensitivity to economic cycles, and competitive pressures in the cruise industry. The upcoming Q2 2026 earnings report on July 28 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →
